Women were less than half of the people tested for almost all of these common medicines.

NCT01103245

Aldosterone and the Metabolic Syndrome

See it on ClinicalTrials.gov β†—

38 people

19 womenmiddle line = equal numbers19 men
Phase
PHASE1
Paid for by
Vanderbilt University Medical Center
Finished
2013-09
Health conditions
Metabolic Diseases, Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders
Who could join
Anyone
Ages
18 Years – 70 Years
Average age
mean 45.3 years
Age 65+
0%
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Not reported

Women left out

  • No pregnant women

    Women who were pregnant could not join.

    β€œPregnancy”
  • No breastfeeding moms

    Women who were breastfeeding could not join.

    β€œBreast-feeding”
  • Had to use birth control

    Women who couldn't or didn't want to use birth control were turned away.

    β€œif of childbearing potential, utilization of adequate birth control and willingness to undergo urine beta-hcg testing prior to drug treatment and on every study day.”
  • No hormone therapy

    Women taking menopause hormones or gender-affirming hormones could not join.

    β€œUse of hormone replacement therapy”
  • Only women past menopause

    Women who could still get pregnant were turned away.

    β€œpostmenopausal status for at least 1 year, or”
  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    β€œβ€¦ired renal function \[estimated glomerular filtration rate (eGFR) of \<60ml/min\] as determined by the four-variable Modification of Diet in Renal Disease (MDRD) equation, where serum creatinine (Scr) is expressed in mg/dl and age in years:”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    β€œCardiovascular disease such as prior myocardial infarction, presence of angina pectoris, significant arrhythmia, congestive heart failure \[Left Ventricular (LV) hypertrophy acceptable\], deep vein thrombosis, pulmonary embolism, second or…”
  • No diabetes

    Women with diabetes were turned away.

    β€œDiabetes type 1 or type 2, a fasting glucose of greater than 110 mg/dL or the use of anti-diabetic medication”
  • No seizures

    Women with epilepsy or past seizures were turned away.

    β€œHistory of serious neurologic disease such as cerebral hemorrhage, stroke, seizure, or transient ischemic attack”

Study titles and rules are shown in their original English.